Notch signaling specifies megakaryocyte development from hematopoietic stem cells - PubMed (original) (raw)
Notch signaling specifies megakaryocyte development from hematopoietic stem cells
Thomas Mercher et al. Cell Stem Cell. 2008.
Abstract
In the hematopoietic system, Notch signaling specifies T cell lineage fate, in part through negative regulation of B cell and myeloid lineage development. However, we unexpectedly observed the development of megakaryocytes when using heterotypic cocultures of hematopoietic stem cells with OP9 cells expressing Delta-like1, but not with parental OP9 cells. This effect was abrogated by inhibition of Notch signaling either with gamma-secretase inhibitors or by expression of the dominant-negative Mastermind-like1. The importance of Notch signaling for megakaryopoietic development in vivo was confirmed by using mutant alleles that either activate or inhibit Notch signaling. These findings indicate that Notch is a positive regulator of megakaryopoiesis and plays a more complex role in cell-fate decisions among myeloid progenitors than previously appreciated.
Figures
Figure 1. The DL1/Notch Axis Induces Megakaryocyte Differentiation In Vitro
(A) Flow-sorted LSK cells were plated on OP9-GFP or OP9-DL1 stroma. (Left panels) Phase-contrast microscopy of day 8 LSK cells/OP9-GFP or OP9-DL1 stroma cocultures. Arrowheads indicate megakaryocytes observed in OP9-DL1 cocultures. Original magnification is ×400. (Middle and right panels) Acetylcholinestesterase (AchE) staining of cytospun cells from cocultures. Original magnification was ×100 and ×600, respectively. Brown coloring indicates positivity for AchE. (B) Flow cytometric analysis of CD45+ cells derived from day 8 LSK/OP9-GFP or OP9-DL1 cocultures. (C) Histogram representation of flow cytometric results presented in (B). Mean ± SEM of five independent flow cytometric analyses after 8 days of coculture is shown. (D) γ-secretase inhibition abrogates biological and molecular effects of DL1 stimulation. LSK cells cultured on OP9-DL1 stroma in the presence of DMSO (control) or Compound E (CompE, 1 µM) were analyzed for megakaryocytic differentiation.
Figure 2. RBPJ/ICN/MAML Complex Mediates Megakaryocyte Development
(A and B) LSK cells were transduced with retroviruses encoding either dnMAML1, ICN1, ICN4, HES1, HES5, or MIG-empty vector control and subsequently plated on OP9-GFP or OP9-DL1 stroma. (C) LSK cells were transduced as in (A) and (B) and plated in presence of 1 µM Compound E or mock (DMSO) control. FACS analyses of CD45+GFP+ cells were performed after 8 days of coculture.
Figure 3. Notch Activates a Megakaryocyte-Specific Transcriptional Program in LSK Cells
(A) RNA from LSK cells cocultured with OP9-GFP or OP9-DL1 in the presence or absence of Compound E (1 µM) for 5 days was used to perform analysis of Hes-1, Gata-1, Fli-1, and PU.1 expression normalized to Gapdh. Mean ± SEM of duplicate experiments is represented. (B) Flow-sorted LSK cells were cultured on stroma (OP9-GFP, OP9-DL1, or OP9-DL1 supplemented with 1 µM Compound E). After 3 days of cocultures, RNA from nonadherent cells was extracted, amplified, labeled, and hybridized on mouse 430.2E Affymetrix chips. Expression data were analyzed for a list of genes positively involved in megakaryopoiesis by using GSEA. Enrichment plot showing upregulation of megakaryocyte-specific genes in OP9-DL1 versus OP9-GFP and OP9-DL1+Compound E. P value and FDR are indicated. (C) Heat map representation of the expression of the top 50 megakaryocyte leading edge genes enriched in OP9-DL1 cultures compared to OP9 and OP9-DL1 supplemented with inhibitor cultures. (D) Venn diagram representation of megakaryocytic genes induced by Notch pathway activation in LSK cells.
Figure 4. Notch Specifies Megakaryocyte Fate at Several Levels of Hematopoietic Differentiation
(A) Limiting dilution assay with LSK cells from wild-type murine bone marrow directly sorted into individual OP9-GFP or OP9-DL1-coated 96-well plates with 1, 2, 5, or 20 cells per well and cultured for 8 days. Cocultures were analyzed under a microscope: wells with visible hematopoietic cells were scored and megakaryocytes were counted. Frequency of megakaryocyte-containing wells is represented, and trend lines were used to estimate the frequency of megakaryocyteforming cells in the LSK population. (B) Flow-sorted Lin−Sca1+Kit+CD34−Flt3− (LT-HSC), Lin−Sca1+Kit+CD34+Flt3− (ST-HSC), and Lin−Sca1+Kit+CD34+Flt3+ (LMPP) cells were plated directly onto OP9-GFP or OP9-DL1 stroma. Flow cytometric analysis was performed after 7 days of coculture. (C and D) RNA from flow-sorted CMP, MEP, and GMP were extracted, amplified, and used for analysis of quantitative expression of Notch receptors (C) and the Notch targets Hes-1, Hes-5, and Hey-1 (D). Results were normalized to GAPDH expression and to the MEP value. Notch3 expression was not detected in any sample. Error bars represent SEM. (E) Flow-sorted CMP were cultured on OP9-GFP or OP9-DL1 for 5 days before analysis by flow cytometry. (F) Flow-sorted MEP were cultured on OP9-GFP or OP9-DL1 for 3 days before analysis by flow cytometry.
Figure 5. DnMAML1 Inhibits Megakaryocyte Development In Vivo
(A) Wild-type bone marrow cells were infected with dnMAML1-encoding or MIG control retroviruses and injected into lethally irradiated syngeneic recipients. Analysis was performed after 3–6 weeks. Flow cytometric analysis of myeloid progenitors within the Lineage−cKit+Sca1− population. Analysis was gated on GFP+ cells. A representative of five independent animals is shown for each group. Mean ± SEM for a total of five independent animals is represented below as histograms. (B) Analysis of the megakaryocyte progenitors c-Kit+CD41+ population (gated on Lineage− GFP+cells) in the bone marrow of MIG versus dnMAML1 recipient animals. (C) FACS analyses of GFP+ dnMAML1 recipient bone marrow cells indicate impaired megakaryocyte development compared to MIG control recipients. (D) Immunohistochemical (IHC) analysis of consecutives bone marrow sections shows reduced staining for the megakaryocyte-specific vWF and mostly GFP− megakaryocytes in dnMAML1 recipients, compared to MIG controls. For both vWF and GFP immunostainings, positive cells show a dark brown color. Black and white arrowheads indicate GFP+ and GFP− megakaryocytes, respectively. Original magnifications are ×100 (vWF) and 31000 (GFP). (E) Fifty megakaryocytes were counted on bone marrow sections stained for GFP, and the percentages of GFP+ megakaryocytes are shown (white histograms). The percentages of GFP+ total bone marrow (BM) cells were assessed in the same recipients by flow cytometry and are also shown (black histograms). Histograms represent mean ± SEM of three independent animals for each group. (F) Ploidy analysis was performed by flow cytometry using propidium iodide and gating on GFP+CD41+ megakaryocytes. Median ploidy is indicated above the histogram (value for diploid state = 2).
Figure 6. DnMAML1 Conditional Knockin Mice Have Impaired Megakaryopoiesis
(A) DnMAML1 cKI-Mx1Cre double transgenic animals were induced with poly(I:C) at 6 weeks of age and analyzed 2–3 weeks later. A representative flow cytometric analysis of myeloid progenitors within the Lineage−cKit+Sca1− population is shown. Mean ± SEM of three independent analyses gated on GFP+ cells is shown below as histograms. (B) Flow-sorted CMPs were plated in methylcellulose cultures supplemented with IL3, IL6, SCF, EPO, and TPO, and colonies were counted after 7 days. GM, granulocyte-macrophage colony; GEMM, granulocyte-macrophage-erythroid-megakaryocyte colony; EMk, erythroid-megakaryocyte colony; E, erythroid colony; Mk, megakaryocyte colony; cKI, conditional knockin. Mean ± SEM (n = 3) are shown.
Figure 7. ICN4 Supports Megakaryocyte Development In Vivo
(A) Rag1−/− bone marrow cells were infected with ICN4-encoding or MIG control retroviruses and injected into wild-type lethally irradiated C57BL/6 recipients. The MEP population was analyzed by flow cytometry. Representative analysis of myeloid progenitor populations in ICN4 recipients compared to controls (GFP+ or GFP− gated population is indicated on the left side). (B) Absolute numbers of MEP are indicated as mean ± SEM of three independent analyses. (C) Megakaryocyte colony-forming unit (CFU-MK) potential from total bone marrow. Mean ± SEM of quadruplicate experiments is represented. (D) Consecutive bone marrow sections from ICN4 and MIG recipients were stained as in Figure 5D. Arrowheads indicate GFP+ megakaryocytes. Original magnification in the upper left four panels is ×100 and in the upper right panel is ×1000. (E) The number of GFP+ megakaryocytes and bone marrow (BM) cells were assessed as in Figure 5E. Histograms represent mean ± SEM of three independent animals in each group. (F) Flow cytometric analysis of megakaryocyte ploidy gated on GFP+CD41+ cells. Median ploidy is indicated in the histograms (value for diploid state = 2). (G) Flow-sorted MEPs from the bone marrow of wild-type C57BL/6 animals were retrovirally transduced with empty control (MIG), ICN1, or ICN4 retroviruses and injected into lethally irradiated recipients with 2 × 105 helper bone marrow cells. Bone marrow cells from recipients were analyzed 12 days posttransplant and analysis was gated on GFP+ cells.
Similar articles
- Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation.
Poirault-Chassac S, Six E, Catelain C, Lavergne M, Villeval JL, Vainchenker W, Lauret E. Poirault-Chassac S, et al. Blood. 2010 Dec 16;116(25):5670-8. doi: 10.1182/blood-2010-05-285957. Epub 2010 Sep 9. Blood. 2010. PMID: 20829371 - Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes.
Mohtashami M, Shah DK, Nakase H, Kianizad K, Petrie HT, Zúñiga-Pflücker JC. Mohtashami M, et al. J Immunol. 2010 Jul 15;185(2):867-76. doi: 10.4049/jimmunol.1000782. Epub 2010 Jun 14. J Immunol. 2010. PMID: 20548034 - Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells.
Neves H, Weerkamp F, Gomes AC, Naber BA, Gameiro P, Becker JD, Lúcio P, Clode N, van Dongen JJ, Staal FJ, Parreira L. Neves H, et al. Stem Cells. 2006 May;24(5):1328-37. doi: 10.1634/stemcells.2005-0207. Epub 2006 Jan 12. Stem Cells. 2006. PMID: 16410393 - Notch signaling in lymphocyte development.
Anderson AC, Robey EA, Huang YH. Anderson AC, et al. Curr Opin Genet Dev. 2001 Oct;11(5):554-60. doi: 10.1016/s0959-437x(00)00232-x. Curr Opin Genet Dev. 2001. PMID: 11532398 Review.
Cited by
- Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
Zhu R, Shirley CM, Chu SH, Li L, Nguyen BH, Seo J, Wu M, Seale T, Duffield AS, Staudt LM, Levis M, Hu Y, Small D. Zhu R, et al. Leukemia. 2024 Jul;38(7):1581-1591. doi: 10.1038/s41375-024-02292-w. Epub 2024 May 29. Leukemia. 2024. PMID: 38811818 - Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation.
Kulkarni PP, Ekhlak M, Dash D. Kulkarni PP, et al. Cell Commun Signal. 2024 Jan 3;22(1):13. doi: 10.1186/s12964-023-01448-y. Cell Commun Signal. 2024. PMID: 38172855 Free PMC article. Review. - Notch signaling functions in noncanonical juxtacrine manner in platelets to amplify thrombogenicity.
Chaurasia SN, Ekhlak M, Kushwaha G, Singh V, Mallick RL, Dash D. Chaurasia SN, et al. Elife. 2022 Oct 3;11:e79590. doi: 10.7554/eLife.79590. Elife. 2022. PMID: 36190110 Free PMC article. - Increased expression of RUNX3 inhibits normal human myeloid development.
Menezes AC, Jones R, Shrestha A, Nicholson R, Leckenby A, Azevedo A, Davies S, Baker S, Gilkes AF, Darley RL, Tonks A. Menezes AC, et al. Leukemia. 2022 Jul;36(7):1769-1780. doi: 10.1038/s41375-022-01577-2. Epub 2022 Apr 30. Leukemia. 2022. PMID: 35490198 Free PMC article. - A Notch/IL-21 signaling axis primes bone marrow T cell progenitor expansion.
Sottoriva K, Paik NY, White Z, Bandara T, Shao L, Sano T, Pajcini KV. Sottoriva K, et al. JCI Insight. 2022 May 9;7(9):e157015. doi: 10.1172/jci.insight.157015. JCI Insight. 2022. PMID: 35349492 Free PMC article.
References
- Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell. 2005;121:295–306. - PubMed
- Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193–197. - PubMed
- Bray SJ. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 2006;7:678–689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA66996/CA/NCI NIH HHS/United States
- P01 CA119070-03/CA/NCI NIH HHS/United States
- P01 CA066996/CA/NCI NIH HHS/United States
- CA119070/CA/NCI NIH HHS/United States
- P01 DK050654/DK/NIDDK NIH HHS/United States
- P01 CA119070/CA/NCI NIH HHS/United States
- P01 CA119070-01A1/CA/NCI NIH HHS/United States
- R01 AI047833/AI/NIAID NIH HHS/United States
- DK50654/DK/NIDDK NIH HHS/United States
- AI047833/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical